Insider Trading Activity Vascular Solutions Inc. (NASDAQ:VASC) – VP Sold 1,849 shares of Stock

ME Staff
-
0

Insider Trading Activity For Vascular Solutions Inc. (NASDAQ:VASC)

Chad Kugler , VP of Vascular Solutions Inc. (NASDAQ:VASC) reportedly Sold 1,849 shares of the company’s stock at an average price of 55.7 for a total transaction amount of $102,989.30 SEC Form

Insider Trading History For Vascular Solutions Inc. (NASDAQ:VASC)

  • On 11/26/2012 Susan Christian, VP, sold 7,648 with an average share price of $14.41 per share and the total transaction amounting to $110,207.68.
  • On 5/1/2013 Richard Nigon, Director, bought 3,000 with an average share price of $15.57 per share and the total transaction amounting to $46,710.00.
  • On 5/17/2013 Paul O’connell, Director, sold 10,000 with an average share price of $16.05 per share and the total transaction amounting to $160,500.00.
  • On 7/25/2013 Paul O’connell, Director, sold 30,000 with an average share price of $16.11 per share and the total transaction amounting to $483,300.00.
  • On 7/25/2013 Howard Root, CEO, sold 21,580 with an average share price of $16.10 per share and the total transaction amounting to $347,438.00.
  • On 7/25/2013 Howard Root, CEO, sold 21,580 with an average share price of $16.10 per share and the total transaction amounting to $347,438.00.
  • On 7/26/2013 Charmaine Sutton, VP, sold 7,538 with an average share price of $16.15 per share and the total transaction amounting to $121,738.70.

    • Analyst Ratings For Vascular Solutions Inc. (NASDAQ:VASC)
    These are 5 Hold RatingsThe current consensus rating for Vascular Solutions Inc. (NASDAQ:VASC) is Hold (Score: 2.00) with a consensus target price of $51.75 , a potential (7.17% downside)

    Analyst Ratings History For Vascular Solutions Inc. (NASDAQ:VASC)

    • On 7/12/2016 Sidoti Downgraded rating Buy to Neutral with a price target of $47.00
    • On 12/2/2016 Needham & Company LLC Downgraded rating Buy to Hold
    • On 12/2/2016 Feltl & Co. Downgraded rating Buy to Hold
    • On 12/5/2016 Canaccord Genuity Downgraded rating Buy to Hold
    • On 12/5/2016 Piper Jaffray Cos. Downgraded rating Overweight to Neutral

    About Vascular Solutions Inc. (NASDAQ:VASC)
    Vascular Solutions, Inc. is a medical device company focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The Company’s product line consists of devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein practices around the world. Its products include GuideLiner catheters, Pronto catheters, Vein catheter reprocessing, Micro-introducer kits, Hemostatic patches, Radial access products, Langston catheters and D-Stat Flowable hemostat. The Company’s product portfolio includes a spectrum of over 90 products consisting of approximately 900 stock keeping units (SKUs) covering an array of blood clotting devices, extraction catheters, access catheters, guide extension catheters, micro-introducer kits, guidewires, snare and retrieval devices, a reprocessing service for radiofrequency catheters and a laser and procedure kits for the treatment of varicose veins.

    Recent Trading Activity for Vascular Solutions Inc. (NASDAQ:VASC)
    Shares of Vascular Solutions Inc. closed the previous trading session at 55.72 down -0.03 -0.04% with 207,597 shares trading hands.